Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 14994

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : November | Volume : 16 | Issue : 11 | Page : EC16 - EC19 Full Version

Determination of C,c,E and e Antigens Prevalence in Rh D Negative Individuals: Is it Good Exercise with Utilities in Clinical Blood Transfusion Practices?


Published: November 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/58527.17131
Manoj A Kahar

1. Consultant Pathologist, Department of Pathology, Bhanumati Clinical Laboratory, Navsari, Gujarat, India.

Correspondence Address :
Manoj A Kahar,
G-19, Bhanumati Clinical Laboratory, Devdarshan Apartment,
Navsari-396445, Gujarat, India.
E-mail: manoj_kahar@yahoo.com

Abstract

Introduction: Besides D antigen, C,c,E and e antigens of Rh blood group system are the most important antigens involved in alloimmunisation. The prevalence of C,c,E and e antigens in Rh D negative individuals in local population has many utilities in transfusion medicine practice.

Aim: To determine the prevalence of C,c,E and e antigens in Rh D negative individuals.

Materials and Methods: This prospective observational study was performed at Bhanumati clinical laboratory, Navsari, Gujarat, India, from January 2020 to January 2022. A total of 270 Rh D negative samples irrespective of ABO blood group status were typed for C,c,E and e antigen using monoclonal reagents from two different manufacturers using conventional tube technique. The most likely phenotype and genotype were determined using reference textbooks. Possibility of weak D in these 270 samples was ruled out using polyspecific Antihuman Globulin Reagent performing test for weak D antigens. Results were analysed using Excel spread sheet.

Results: Prevalence of C,c,E, and e antigen in the 270 Rh D negative samples were, C (17, 6.29%), c (267, 98.88%), E (1, 0.37%) and e (270, 100%). Most probable genotypes were dce/dce(rr), dCe/dce(r’r), dCe/dCe(r’r’) and dcE/dce(r”r).

Conclusion: Data obtained of C,c,E and e antigen prevalence in Rh D negative individuals is having varied utilities in blood transfusion services such as formulating rare blood group registry, preparing in house screening and panel red cells, and maintaining inventory of rare blood group units using freezing technology, if available.

Keywords

Alloimmunisation, Haplotypes, Red cell panel, Rh antigen

The Rh blood group system is the second most important blood group system in terms of transfusion, as the Rh system antigens are very immunogenic (1). With 56 antigens so far describe, Rh system is largest of all the blood group system (2). The unusually large number of Rhesus antigens (56 antigens) is attributable to complex genetic basis.Two adjacent genes Rh D (carrying the D antigen) and RhCE (carrying the C or c antigen and the E or e antigen) found at the RH locus (assigned to chromosome 1), are responsible for formation of Rh blood group antigens (3). Out of the 56 antigens belonging to Rh system, the five most important Rh antigens D, C, c, E and e are the causes of most alloimmunisation following blood transfusion or pregnancy (4),(5),(6),(7).

Most of the studies on red cell alloimmunisation done in India have found that antibodies to Rh blood group system antigens were the most common one to be detected ranging from 67-95% (8),(9),(10),(11),(12),(13),(15). The knowledge of antigen frequency in the local population is clinically important as one can predict the common alloantibodies that could be formed in patients receiving transfusions and also helps in selection of antigen negative blood units for patients with presence of such alloantibodies. With the above primary objective, the present study was performed to determine antigen prevalence of C, c, E and e antigen in Rh D negative individuals of Navsari district and to create a data base for its further use as and when needed.

Material and Methods

This prospective observational study was performed at Bhanumati clinical laboratory, Navsari, Gujarat, India, from January 2020 to January 2022.

Sample Collection

A 5 mL of blood was collected from 270 known Rh D negative blood group individuals of Navsari District, irrespective of ABO blood group status in K3 EDTA (tripotassium Ethylenediaminetetraacetic acid) (Labtech Disposable blood collection tube). Rh D negative status in these sample was first established by testing with two different IgM Monoclonal anti-D reagents (Tulip Diagnostics private Ltd. and J. Mitra and Company Private Ltd.) by conventional tube technique as per the guidelines by British Committee for Standards in Haematology for pretransfusion compatibility procedures in blood transfusion laboratories (16). Test for weak D Antigen was also performed on all these 270 samples using polyspecific Antihuman Globulin Reagent (Tulip Diagnosis Private Ltd.) to rule out possibilities of weak D by conventional tube technique.

Inclusion and Exclusion criteria: Sample showing clear cut Rh negative samples were included in the study. EDTA samples containing small fibrin clots and haemolysis were excluded from the study.

All these 270 sample were typed for the presence of C,c,E and e antigens using the Eryclone Monoclonal Rh/hr Typing reagents (Tulip Diagnostics private limited) by conventional tube technique. The results were reconfirmed using a second set of (monoclonal antisera Anti-C, Anti-c, Anti-E and Anti-e) Sera clone (Bio-Rad laboratories).

Sample size calculation: Most studies published from India determining the antigen frequency of C,c,E and e antigen in Rh D Negative individuals have a sample size of less than 100 (17),(18),(19). However the current study has a larger sample size of 270 samples. Sample size of 270 samples in the current study provides a confidence level of 90% with a margin error of 5% (20).

The quality of these blood grouping reagents were verified as published in literature giving a 2+reaction in undiluted reagent (21),(22). Appropriate negative and weak-positive controls were used while performing the antigen typing for C,c,E and e antigen in these 270 sample. These controls were selected from Red cell panel (ID-Diapanel) for antibody detection procured from Bio-Rad laboratories.

Statistical Analysis

Results were analysed using excel spread sheet.

Results

Prevalence of C,c,E, and e antigen in the 270 Rh D negative samples in current study were C (17/270,6.29%), c (267/270,98.88%), E (1/270,0.37%) and e (270/270,100%). The highest antigen prevalence was observed for e antigen (100%) and least was observed for E antigen (0.37%). The result obtained for C,c,E and e antigen prevalence are represented in (Table/Fig 1).

Based on the reaction pattern observed with five antisera (anti-D, anti-C, anti-c, anti-E and anti-e), the most probable phenotypes described in current study were dce/dce(rr), dCe/dce(r’r), dCe/dCe(r’r’) and dcE/dce(r”r) (3). The frequency of these probable phenotypes are depicted in (Table/Fig 2).

Discussion

Rh blood group system is one of the most important protein based blood group system. The two adjacent genes at the RH locus that are responsible for expression of Rh protein, Rh D and RHCE are closely linked near the 3’ end of chromosome 1p36.11 (21). Rh D Negative persons inherit only a single RHCE gene from each parent. The Rh genes behave as autosomal co-dominant allele. There are eight possible haplotype arrangements of Rh genes on the short arms of chromosome 1, Viz Dce, DCE, DCe, DcE, dce, dCE, dCe and dcE (Table/Fig 3) (23).

As with other blood group genes, the offsprings inherit a set of genes from each parent. In the case of Rh, this is in the form of an Rh haplotype from each parent (Table/Fig 4).

Using the five readily available Rh antisera (anti-D, anti-C, anti-c,anti-E and anti-e), one is able to determine the Rh phenotype of the red cell being tested. Based on the phenotype and the gene frequencies for the population under study, one is able to estimate the most probable Rh genotype (3). Determining probable genotypes is useful for parentage studies are well as for population studies. Probable genotype also may be useful in predicting the potential for haemolytic disease of new born in offspring of Rh-negative women with an Rh antibody (Table/Fig 5).

Out of the C,c,E and e antigens of Rh blood group system, typed in the current study, e and c antigen were found with a higher frequency of 100% and 98.9% respectively, which is comparable with similar studies published from India (17),(18),(19).

The C and E antigens had a lower frequency of with 6.3 and 0.3% in the present study. The frequency of C antigen in present study is comparable with two similar studies by Thakral B et al., and Lamba DS et al., (17),(18). However, in study by Makroo R et al., frequency of C antigen is reported as 33.7% (19). The frequency of E antigen (0.3%) was the least in the present study between C,c,E and e antigens. Three studies used for comparison also had the E antigen as the least frequency in Rh D negative individuals (17),(18),(19). However, the current study has a frequency of E antigen only 0.3% which is in contrast with reported frequencies of 1.8 to 4.3% reported in similar studies (17),(18),(19). This could be due to some ethnic geographic variation as current study was performed in Western India. while all the other three studies used for comparisons were performed in North India. This discrepancy needs to be further evaluated by larger series from Western India determining frequency of E antigen in Rh D individuals (Table/Fig 6) (17),(18),(19).

The phenotypes found in the current study were rr, r’r,r’r’, and r”r with highest incidence of rr (93.3%) and least incidence of r”r (0.3%). The other Rh phenotypes in Rh D individuals like r”r”, r’r”, ryry, ryr’ and ryr” were not found in the current study and they are also listed as rare in standard text books (3),(21),(24). A rare blood is the one that on the series of the blood group characteristics, is found in a frequency of 1:1000 random samples in a given population (25),(26). The phenotypes observed in Rh D individuals in the present study were comparable with similar studies from Northern India with only exception of prevalence of C antigen in 33.7% in a study by Makroo R et al., (19). The results of such antigen typed individuals may be useful in determining antigen frequency in local population and preparing data base of C, c, E, e antigens in Rh D negative individuals.

Use of such database is as follows:

1. Providing phenotype matched antigen negative blood unit: The relative difficulties in providing compatible blood products are determined by the frequency of the antigen in the population and by the clinical significance of the antibody. Knowing the frequency of the antigen(s) in the population is helpful when determining the number of units that should be antigen-typed to find a sufficient number to fulfil the crossmatch request. To determine the number of units to test, divide the number of units requested by the frequency of antigen negative individuals in the population (8),(11),(10),(24),(27).
2. Preparation of selected cell panel in complex/multiple antibody identification cases: Selected cell preparation from the known database of such phenotyped Rh D negative red cells can be chosen for the specific antigen they carry or lack, to confirm or rule out the presence of antibodies (3),(21),(24).
3. To assess the quality of commercial antisera anti-C, anti-c, anti-E and anti-e: Well-characterised cells from the database, may be used to check the quality of commercial antisera anti-C, anti-c, anti-E and anti-e, for their sensitivity and specificity. Cell having single dose of specific antigen (heterozygous) are preferred for quality check of the antisera (21),(22).
4. Use of rr cells for differential adsorption: Differential adsorption can be performed when a patient’s phenotype is unknown and performing antigen-typing is not an option (i.e., positive DAT or transfused within the last three months). For this method, group O cells with the following phenotypes are used: R1R1, R2R2, and rr (3),(24),(28).
5. Preparing in house screening and panel cells respectively for antibody detection and identification: Such specifically phenotyped red cells can be used in preparing in house screening and panel cells, respectively for detection and identification of antibodies against red cell antigens (29),(30).
6. Freezing rare phentoyped red cells and autologous red cells for future use: Rare blood group phenotyped red cells and autologous red cells can be stored in frozen state for use in future, if facilities are available at the blood centres (3),(21),(24).

Limitation(s)

The C, c, E and e antigens were determined by serological methods in the current study and none of the results was confirmed by molecular typing. Molecular typing would confirm the genotype for the blood group antigens.

Conclusion

The current study provided institute a good database of prevalence of C, c, E and e antigens in Rh D negative individuals, such database has multiple utilities in immunohaematology laboratory and clinical transfusion practices like, ease of providing blood unit with rare antigen phenotype, selective red cell panel preparation for use in complex antibody identification cases, assessing the quality control of commercial antisera anti-C, anti-c, anti-E, and anti-e, use of rr cells for differential adsorption, use of such phenotyped cells in preparing in house screening and panel cells for antibody detection and identification, freezing red cells with rare blood group antigens, if facilities are available for future use. Multicentre studies in determining frequency of C, c, E and e antigens in Rh D negative individuals will create a large database, throughout different geographic regions and at national level and can be made available to Transfusion Medicine specialists for further use.

References

1.
Flegel WA. The genetics of the Rhesus blood group system. Blood Transfus. 2007;5(2):50-57.
2.
Red Cell Immunogenetics and Blood Group Terminology. https://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology.
3.
Sally V R. Textbook of Blood Banking and Transfusion Medicine. 2nd Ed. 2005.
4.
Thakral B, Saluja K, Sharma RR, Marwaha N. Red cell alloimmunization in a transfused patient population: A study from a tertiary care hospital in north India. Hematology. 2008;13(5):313-18. [crossref] [PubMed]
5.
Philip J, Biswas AK, Hiregoudar S, Kushwaha N. Red blood cell alloimmunization in multitransfused patients in a tertiary care center in Western India. Lab Med. 2014;45(4):324-30. [crossref] [PubMed]
6.
Zaman S, Chaurasia R, Chatterjee K, Thapliyal RM. Prevalence and specificity of RBC alloantibodies in Indian patients attending a tertiary care hospital. Adv Hematol. 2014;2014. [crossref] [PubMed]
7.
Nathani KJ, Patel J, Modi P, Pandya A, Wadhwani S, Jarag M, et al. Prevalence of Red Cell AlloAntibodies & AutoAntibodies in Patient & Donor attending a Tertiary Care Hospital in South Gujarat. Int J Contemp Med Researc. 2021;8(3):01-05. Available from: www.ijcmr.com.
8.
Shukla JS, Chaudhary RK. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing haemodialysis. Indian J Pathol Microbiol. 1999;42(3):299-02. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10862287
9.
Patel J, Shukla R, Gupte S. Red cell alloimmunization in multitransfused patients and multiparous women. Indian J Hematol Blood Transfus. 2009;25(2):49-52. [crossref] [PubMed]
10.
Chaudhari CN. Red cell alloantibodies in multiple transfused thalassaemia patients. Med J Armed Forces India . 2011;67(1):34-37. Available from: http://dx.doi.org/10.1016/S0377-1237(11)80008-0. [crossref] [PubMed]
11.
Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology. 2010;15(3):174-77. [crossref] [PubMed]
12.
Pahuja S, Gupta SK, Pujani M, Jain M. The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi. Blood Transfus. 2011;9(4):388-93.
13.
Vilas M. Sangole D. Alloimmunisation of red blood cells in multitransfused patients. Int J Heal Sci Res. 2013;3(5):39-41.
14.
Kahar M. Frequency of red cell alloantibodies in pregnant females of Navsari District: An experience that favours inclusion of screening for irregular erythrocyte antibody in routine antenatal testing profile. J Obstet Gynecol India. 2018;68(4):300-05. [crossref] [PubMed]
15.
Mangwana S, Kacker A, Simon N. Red cell alloimmunization in multi-transfused, oncology patients: Risks and management. Glob J Transfus Med. 2019;4(1):74-78. [crossref]
16.
British Committee for Standards in Haematology, Milkins C, Berryman J, Cantwell C, Elliott C, Haggas R, et al. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med. 2013;23(1):03-35. [crossref] [PubMed]
17.
Thakral B, Saluja K, Sharma RR, Marwaha N. Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in north Indian blood donors. Transfus Apher Sci. 2010;43(1):17-22. Available from: http://dx.doi.org/10.1016/j.transci.2010.05.006. [crossref] [PubMed]
18.
Lamba DS, Kaur R, Basu S. Clinically significant minor blood group antigens amongst North Indian donor population. Adv Hematol. 2013;2013:215454. [crossref]
19.
Makroo R, Gupta R, Bhatia A, Rosamma NL. Rh phenotype, allele and haplotype frequencies among 51,857 blood donors in North India. Blood Transfus. 2014;12(1):36-39.
20.
https://www.calculator.net/sample-size-calculator.html.
21.
Cohn CS, Delaney M, Johnson ST, Katz LM (editors). Technical Manual. 20th ed. American Association of Blood Banks; 2020.
22.
Guidelines for the Blood Transfusion Services in the United Kingdom. 8th ed. 2013.
23.
Qureshi R. Introduction to Transfusion Science Practice. 6th ed. British Blood Transfusion Society; 2015.
24.
Harmening DM. Modern Blood Banking & Transfusion Practices. 7th ed. 2019.
25.
Reesink HW, Engelfriet CP, Schennach H, Gassner C, Wendel S, Fontão-Wendel R, et al. Donors with a rare pheno (geno) type. Vox Sang. 2008;95(3):236-53. [crossref] [PubMed]
26.
Joshi SR, Vasantha K. A profile of rare bloods in India and its impact in blood transfusion service. Asian J Transfus Sci. 2012;6(1):42-43. [crossref] [PubMed]
27.
Kulkarni S, Choudhary B, Gogri H, Sharma JMM. Red cell antigen phenotypes in blood donors & thalassaemia patients for creation of red cell antigen-matched inventory. Indian J Med Res. 2020;152:273-79. [crossref] [PubMed]
28.
Barros M, Langhi Jr D, Bordin JO. Autoimmune hemolytic anaemia: Transfusion challenges and solutions. Int J Clin Transfus Med. 2017;5:09-18. [crossref]
29.
Salamat N, Bhatti FA, Yaqub M, Hafeez M, Hussain A, Ziaullah. Indigenous development of antibody screening cell panels at Armed Forces Institute of Transfusion (AFIT). J Pak Med Assoc. 2005;55(10):439-43.
30.
Shah R, Harimoorthy V, Shah R, Barot T, Kumar K. Role of extended red cell phenotyping in management of patient with multiple antibodies and their utility in development of indigenous cell panels for antibody screening. Glob J Transfus Med. 2020;5(1):58. [crossref]

DOI and Others

DOI: 10.7860/JCDR/2022/58527.17131

Date of Submission: Jun 18, 2022
Date of Peer Review: Aug 02, 2022
Date of Acceptance: Sep 12, 2022
Date of Publishing: Nov 01, 2022

Author declaration:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? No
• Was informed consent obtained from the subjects involved in the study? No
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jun 22, 2022
• Manual Googling: Aug 25, 2022
• iThenticate Software: Sep 01, 2022 (14%)

Etymology: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com